See the Complete Picture.
Published loading...Updated

Wegovy drives growth: Novo increases sales by 19 percent despite increasing competition

Summary by avisendanmark.dk
In the first quarter of 2025, sales of Wegovy ended at 17.4 billion kroner, according to Novo Nordisk's financial statements.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

avisendanmark.dk broke the news in on Wednesday, May 7, 2025.
Sources are mostly out of (0)